Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

904
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
904
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

881
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
881
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

479
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
479
Endoscopic Procedures V: ERCP01:26

Endoscopic Procedures V: ERCP

5.5K
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
5.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum IFABP level as an index of mucosal health in celiac disease: a small intestinal morphometry study.

Clinical and translational gastroenterology·2026
Same author

The role of integrated gastro-rheumatological care in IBD-associated Spondyloarthritis in achieving joint-gut remission: Four-year outcomes from the real-world SPIB cohort.

Seminars in arthritis and rheumatism·2026
Same author

Editor's Note: γ-Aminobutyric Acid Inhibits Cholangiocarcinoma Growth by Cyclic AMP-Dependent Regulation of the Protein Kinase A/Extracellular Signal-Regulated Kinase 1/2 Pathway.

Cancer research·2026
Same author

From totally laparoscopic to pure robotic pancreatoduodenectomy: A propensity score matching analysis of a single-center experience.

Surgery·2025
Same author

Primary biliary cholangitis (PBC): evolving approaches and expert perspectives.

Expert review of gastroenterology & hepatology·2025
Same author

Corrigendum to 'cAMP stimulates the secretory and proliferative capacity of the rat intrahepatic biliary epithelium through changes in the PKA/Src/MEK/ERK1/2 pathway' (J Hepatol 41 [2004] 528-537).

Journal of hepatology·2025

Related Experiment Video

Updated: Mar 27, 2026

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
12:36

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

18.0K

Current Targets for Primary Sclerosing Cholangitis.

Irene Pierantonelli1, Antonio Benedetti1, Marco Marzioni1

  • 1Department of Gastroenterology and Hepatology, Università Politecnica delle Marche, Ancona, Italy.

Current Drug Targets
|January 14, 2016
PubMed
Summary
This summary is machine-generated.

Primary sclerosing cholangitis (PSC) is a rare liver disease causing bile duct inflammation and damage. This review summarizes current and past therapeutic strategies for PSC, highlighting the need for better treatments.

Keywords:
Primary sclerosing cholangitischolestasisdiagnosisinflammatory bowel diseasepathogenesistreatment

More Related Videos

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

21.1K
Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma
05:22

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Published on: February 13, 2026

166

Related Experiment Videos

Last Updated: Mar 27, 2026

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
12:36

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

18.0K
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

21.1K
Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma
05:22

Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma

Published on: February 13, 2026

166

Area of Science:

  • Hepatology
  • Immunology
  • Gastroenterology

Background:

  • Primary sclerosing cholangitis (PSC) is a chronic biliary disease.
  • It involves liver inflammation, cholangiocyte damage, fibrosis, and cirrhosis.
  • PSC increases the risk of cholangiocarcinoma and has poorly understood etiopathogenesis.

Purpose of the Study:

  • To provide a comprehensive summary of current and historical therapeutic approaches for PSC.
  • To highlight the challenges in PSC treatment due to incomplete understanding of its causes.
  • To review potential strategies impacting disease progression.

Main Methods:

  • Literature review of past and present therapeutic strategies for PSC.
  • Analysis of studies evaluating novel treatment approaches.
  • Synthesis of information on disease progression and management.

Main Results:

  • Current therapies for PSC have limited efficacy due to the disease's complex nature.
  • Research is ongoing to identify effective treatments targeting immune-mediated damage and fibrosis.
  • Several potential therapeutic avenues are under investigation.

Conclusions:

  • Effective treatments for PSC remain a significant unmet need.
  • Further research into the etiopathogenesis of PSC is crucial for developing targeted therapies.
  • This review offers insights into the evolving landscape of PSC treatment options.